Reducing Cardiovascular Risk With PCSK9 Inhibitors in Patients With Recent Acute Coronary Syndromes

July 10, 2021

In this program, lipid expert Dr. James Underberg will describe best practices with PCSK9 inhibitors in patients who have experienced an ACS.

0.50 Credits

From Glycemic Control to Cardiorenal Protection: Improving Outcomes With SGLT2 Inhibitors

May 15, 2021

Experts Dr. Lawrence Leiter (Chair), Dr. Jennifer Green, Dr. Javed Butler, and Dr. David Cherney from multiple specialties (endocrinology, cardiology, and nephrology) will through lecture, case presentations, and panel discussion, provide perspectives on translating evidence into clinical practice and indicate considerations for using SGLT2 inhibitors safely and effectively in patients with, and at high risk for CV disease, HF, and chronic kidney disease (CKD).

2.00 Credits

Practices for Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Obstructive Sleep Apnea

August 23, 2020

Practices for Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Obstructive Sleep Apnea

CME 0.75 Credits

Medical Cannabis The Science. The Research. The Risk.

February 28, 2020

“Medical Cannabis: The science. The research. The risks.” is a full spectrum education program for the medical community. This conference held on November 15th, 2019 in New York focuses on the scientific and legal knowledge of healthcare professionals (physicians, pharmacists, physician assistants, nurse practitioners) and medical legal professionals. Anyone who wants to learn more about the science and potential liability surrounding cannabis will benefit from it.

No Credit Available

Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving Outcomes

January 26, 2020

In this program, sleep experts Dr. Richard Bogan (Chair), Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.

No Credit Available

Narcolepsy in Children: Addressing the Challenges and Improving the Outcomes

January 04, 2020

In this program, pediatric sleep disorder experts Kiran Maski, MD, MPH; Judith Owens, MD, MPH, and Michael Strunc, MD will describe best practices in diagnosis and treatment of narcolepsy.

No Credit Available

Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk: Identifying Effective Strategies for Patients with Diabetes

November 30, 2019

In this program, a panel of experts will discuss the latest guidelines for managing LDL-C in patients with diabetes, interpret data with nonstatin, LDL-C-lowering therapies, describe improving access to PCSK9 inhibitors and tips for achieving earlier access,

No Credit Available

Using Narcolepsy Medications Wisely: Tips for Clinical Practice

October 16, 2019

Audio presentations on the considerations and treatment options for the management of Narcolepsy

No Credit Available

Narcolepsy in Children: Overcoming Barriers and Improving Outcomes

October 04, 2019

Narcolepsy in Children

No Credit Available

Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to Practice

July 02, 2019

In this symposium, lipid experts Dr. Robert Giugliano, Dr. Marc Sabatine, and Dr. James Underberg will describe best practices for internists in managing LDL-C and reducing the risk for major cardiovascular events with the addition of nonstatin therapy.

No Credit Available